123 filings
Page 4 of 7
6-K
oyh1cv 800qe4o7w8
31 Mar 23
NewAmsterdam Pharma Reports Full Year 2022 Financial Results and Provides Corporate Update
8:36am
S-8
zr0qm
31 Mar 23
Registration of securities for employees
7:36am
6-K
eriv2mah 4jz1f
7 Mar 23
Current report (foreign)
8:21am
6-K
x1swfyd oeq3tv2
3 Mar 23
Current report (foreign)
4:50pm
6-K
5fc2ofva482
14 Feb 23
Current report (foreign)
8:17am
6-K
5bh8y2yo r7n0m78n
6 Feb 23
NewAmsterdam Pharma Appoints John W. Smither to its Board of Directors
8:10am
424B3
z4mc8xwrpjoh
31 Jan 23
Prospectus supplement
4:03pm
EFFECT
plrploe6rcskepv0n 10
31 Jan 23
Notice of effectiveness
12:15am
CORRESP
g75uvtp 31j0
26 Jan 23
Correspondence with SEC
12:00am
6-K
ogql88o
17 Jan 23
Current report (foreign)
8:11am
F-1/A
q4h 3cdv6u
17 Jan 23
Registration statement (foreign) (amended)
8:06am
CORRESP
v4v0kzq 35d
17 Jan 23
Correspondence with SEC
12:00am
6-K
7l4s0vm qv47uzrb
11 Jan 23
Current report (foreign)
5:00pm
6-K
0x79f4dvo62 9utmz
9 Jan 23
Current report (foreign)
8:31am
UPLOAD
5fcyqpnt2je 8wo
5 Jan 23
Letter from SEC
12:00am
F-1
7xmotgv k5
19 Dec 22
Registration statement (foreign)
6:22pm
6-K
lzfrr2ujtsh5a1sfux
19 Dec 22
NewAmsterdam Announces Appointment of David Topper as Chief Financial Officer
4:23pm
20-F
57qatig
28 Nov 22
Annual report (foreign)
4:41pm
6-K
9p6u2lzmxay zsqv2
23 Nov 22
Current report (foreign)
4:36pm
CERT
qrk1z53hmz5hoq
22 Nov 22
Certification of approval for exchange listing
9:52am